U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite
Endo International plc announced that it received U.S. Food and Drug Administration (FDA) approval...
Read MoreEndo International plc announced that it received U.S. Food and Drug Administration (FDA) approval...
Read MoreWhile the increasing desire to enhance physical appearance and the changing attitudes towards...
Read MoreHarley Academy have launched a compelling new eLearning course for Aesthetics practitioners:...
Read MoreEpisode 6 – Bob Khanna In partnership with the Aesthetic Multispecialty Society, we ask...
Read More“The Return of Aesthetic Patients Post COVID-19” report finds the majority of consumers are eager to
resume treatments, and suggests practitioner steps to ensure patient confidence
Dyspigmentation of the face is a concern of many patients. It is difficult to treat, especially in...
Read MoreMost clinic doors will open in July and things will be very, very different. One major change will...
Read MoreIn recognition that practitioners will be setting up and back in clinic during July,...
Read More